Expert insight 23 Apr 2014

What ‘The Complex Journey of a Vaccine’ is all about

Did you know that with the exception of safe drinking water, no other public health intervention has had such a major impact upon mortality reduction as vaccines have had? Figures talk by themselves. In 2012 alone, 111 million children were given vaccines against life threatening diseases, preventing some 2 to 3 million deaths that year....

Read more
Report 20 Apr 2014

Case study: Malaria

Read more
Report 15 Apr 2014

Case study: Dengue

Read more
Infographic 4 Apr 2014

World Health Day 2014: Protect yourself from vector-borne diseases

Read more
Report 3 Apr 2014

Innovative biopharmaceutical industry perspectives on universal health coverage, proposed public policy principles (2014)

Read more
Expert insight 2 Apr 2014

Pharma innovation – giving value for value received

The Chief Innovation Officer of the company that invented the way crisps in a tube are packed (rather than the wasteful packages full of air) coined the phrase: “What we’ve done to encourage innovation is make it ordinary.” The bio-pharmaceutical scientists and researchers deal with more complex issues than the humble potato crisp, such as...

Read more
External study 2 Apr 2014

Measuring the economic footprint of the pharmaceutical industry

Read more
Report 1 Apr 2014

AIPM & IFPMA: Recommendations for the Development and Implementation of Corporate Healthy Lifestyle Programs

Read more
Expert insight 31 Mar 2014

It’s Time to Agree on Universal Health Coverage Guiding Principles

With 1 billion people lacking access to basic health care and more than 2 billion people lacking regular access to essential medicines, governments are increasingly placing emphasis on the promise of universal health coverage (UHC). UHC has become an increasingly salient issue for developed and developing countries alike in the context of the global economic...

Read more
Report 30 Mar 2014

2013 Pharmaceutical R&D projects to develop new cures for patients with neglected conditions

Read more
Video 28 Mar 2014

IFPMA 2014 interview Series: Andrew Jenner’s take on ‘Value of innovation’

In this video, Andrew Jenner, IFPMA’s Executive Director, Corporate Strategy & Legal Affairs, gives the pharmaceutical industry perspective on innovation. Despite the growing scientific, intellectual property and regulatory challenges of the past decades, over 340 new drugs have been introduced since 2002 to treat different chronic and non-chronic diseases. This can be considered as a...

Read more
Report 27 Mar 2014

Fight the Fakes – 5 Myths About Fake Medicines

Read more